feed,title,long_url,short_url
SeekingAlpha,Bristol Myers Squibb's opdivo combo fails to meet main goals in late-stage cancer trial,https://seekingalpha.com/news/3715897,
SeekingAlpha,XP reports 88% growth in Q2 assets under custody,https://seekingalpha.com/news/3715896,
SeekingAlpha,Byrna Technologies prices upsized equity offering at $21,https://seekingalpha.com/news/3715895,
SeekingAlpha,Sprouts Social expected to benefit from new social commerce integrations,https://seekingalpha.com/news/3715894,
SeekingAlpha,ReneSola: I Buy The Turnaround,https://seekingalpha.com/article/4439498,
